Redeye Feed

2024-11-20 10:35:00 Lytix Q3 2024 - First Patient in NeoLIPA

2024-11-20 10:33:00 Dala Energi - The case has been significantly de-risked

2024-11-19 16:05:00 Coegin Pharma Q3 - Further business developments

2024-11-19 10:54:00 Redeye IT Consulting Q3 2024 - Cautious Optimism Looking into 2025

2024-11-19 10:50:00 Redeye IT Consulting Q3 2024 - Cautious Optimism Looking into 2025

2024-11-18 10:58:00 BioArctic Q3 2024 - Positive CHMP opinion a relief for the share

2024-11-18 10:55:00 Cantargia Q3 2024 - IL1RAP Companion Diagnostic Next

2024-11-18 10:27:00 OncoZenge Q3 2024 - Approaching lift-off

2024-11-18 10:25:00 Starbreeze - Shift in development focus

2024-11-18 10:23:00 Better Collective - Short term uncertainty, positive long-term outlook

2024-11-18 10:22:00 Paxman - Potential for a stellar 2026

2024-11-18 10:17:00 Navigo Q3 2024: A stumble on the road to recovery

2024-11-18 10:16:00 CTEK - Heading into peak season

2024-11-18 10:15:00 BeammWave - Customer activity remains high

2024-11-18 10:14:00 Precise Biometrics - Back in black

2024-11-15 13:14:00 Kontigo Care - Directed share issue of cSEK10.4m

2024-11-15 13:13:00 Smart Eye - Automotive ramp-up edging closer

2024-11-15 13:12:00 Raketech - Lowered expectations

2024-11-15 13:11:00 Thunderful Group - New strategy announced

2024-11-15 13:10:00 Fable Media Group - Continues to outperform in a tough market

2024-11-15 13:08:00 Surgical Science Q3 2024 - Sequential improvements continue

2024-11-14 16:30:00 OssDsign Q3 - Better than expected

2024-11-14 15:27:00 Cinclus Pharma Q3 - Progress in preparations ahead of pivotal study

2024-11-14 15:26:00 Alzecure Q3 2024 - Business development on the agenda

2024-11-14 15:25:00 Alzinova Q3 - A new sheriff in town

2024-11-14 15:21:00 Lifecare Q3 2024 - Steady progress but veterinary launch postponed

2024-11-14 15:19:00 Sivers Semiconductors - Promising long-term prospects, but short-term financing a question mark

2024-11-14 15:18:00 Gentoo Media - Solid cash generation

2024-11-14 15:16:00 BrightBid: Setting the Organisation for Cost-Efficient Growth

2024-11-13 17:57:00 Physitrack Q3 2024 - Soft short-term outlook

2024-11-13 17:56:00 Scibase Q3’2024 - Financing to accelarate US

2024-11-13 17:55:00 Moberg Pharma Q3’2024 - Launch in focus awaiting top line data

2024-11-13 17:53:00 InfraCom - Improved outlook buoys 2025e

2024-11-13 17:52:00 EG7 - Limited impact from softer margin guidance

2024-11-12 17:54:00 Scandion Oncology Q3 2024 - Searching for a partner

2024-11-12 17:53:00 Nanologica Q3 2024 - Poised for harvest season?

2024-11-12 17:51:00 Genovis Q3 2024 - Beat across the board

2024-11-12 17:50:00 Kontigo Care Q3 2024 - Positive but complex outlook

2024-11-11 16:28:00 Bredband2 - Q3 Review – Continued Progress

2024-11-11 16:26:00 Egetis Q3 2024: Financing secured, progress with Emcitate in US and EU

2024-11-11 16:21:00 Serstech - Outlook remains strong

2024-11-11 16:20:00 Mendus Q3 2024 - Minor catalysts in Q4 2024e, CADENCE in focus

2024-11-11 16:19:00 SenzaGen Q3 - A solid quarter

2024-11-11 16:18:00 Arise - Marching on

2024-11-08 13:34:00 Acarix Q3 2024 - Setting the stage for an exciting 2025

2024-11-08 13:33:00 Oncopeptides Q3 2024 - Sluggish Growth

2024-11-08 13:31:00 Ascelia Pharma Q3 Update: Cash and progress

2024-11-08 13:30:00 G5 Entertainment - Positive start to Q4, limited visibility for new game launches

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Redeye

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden